Moody's assigns 'Baa2' rating to Boston Medical Center's bonds

Moody's Investors Service has assigned a "Baa2" rating to Boston Medical Center's proposed $180 million of series 2016E revenue bonds.

The rating assignment is based on several factors, including Boston Medical Center's key role as a healthcare provider in the area and as a provider of health insurance services through an affiliated insurance plan.

BMC also faces challenges, including a payer mix heavily weighted toward governmental payers.

The outlook is stable, reflecting Moody's Investors Services' view that BMC will continue to receive supplemental funding and generate adequate margins.

More articles on healthcare finance:
CMS offers bundled payment webinar
Power plant tax dispute risks shuttering Texas community hospital: 5 things to know
5 findings on Brexit's anticipated effect on NHS

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months